09.30.23 -- USP Unpacks The Evolving HCP Identification And Quantitation Story Behind <1132.1>

FEATURED EDITORIAL

USP Unpacks The Evolving HCP Identification And Quantitation Story Behind <1132.1>

Geopartnering With Global Suppliers

WuXi Biologics 2023 CDMO Leadership Awards Winner Interview

Mechanistic Modeling To Optimize rAAV Production For Gene Therapy

Pfizer CentreOne 2023 CDMO Leadership Awards Winner Interview

August 2023: CDMO Opportunities And Threats Report

Effective Quality CDMO Contracting

Comparing Alternative mAb Purification Tech

New ISO 14644-21:2023 Addresses Reducing Sampling Errors With Airborne Particle Counters

Japan’s Global Lessons In Outsourcing

INDUSTRY INSIGHTS

Meeting The Growing Demand For Prefilled Syringes

RFID-Based Unit-Level Traceability: Optimizing Fill/Finish Lines

Leveraging The Bolar Exemption To Accelerate Market Access

Mass Spectrometry For Biotherapeutics With A Mass Spec Team

Successfully Producing Insoluble Proteins Using Inclusion Bodies

SMARTag Technology, From Bertozzi Lab To Best-In-Class ADCs

Digital Pathology And Machine Learning

Addressing Key Challenges Of High-Concentration Formulation Development

Delivering Genetic Editing Therapies To Market

Critical Steps To Optimize Viral Vector Manufacturing With CDMOs

Unlocking The Full Potential Of Genomic Medicine

GMP Tissue Sourcing

Gene Therapy: Helping To Bring New Innovations To Light

A Smarter Strategy For Optimizing Oncology Drug Products

Prioritize Solvent Recycling And Recovery To Realize Your Green Goals

Paving The Way For Tomorrow’s Medicines

Zydis Orally Disintegrating Tablets (ODTs) vs. Standard Tablets (STs)

Taste Masking 101: Sensory And Performance Evaluation

Mitigating Risk In Tech Transfer: Finding The Right Partner

Build vs. Outsource For Drug Development And Manufacturing

Evaluating Biomanufacturing Possibilities To Meet Patient Needs

Transitioning From A Vial To PFS Or Cartridge In An Auto-Injector Device

GMP-Validated Adventitious Virus Testing By Next-Generation Sequencing

3 Keys To Success When Planning With Your CMO Partner

Liposomes: Challenges And Opportunities

Alternatives To In Vivo Assays For Biosafety Testing Of Biologics

Overcoming Inventory Challenges For A Complex, Global Study

Tailored CMC Solutions To Overcome Challenges In Development Programs

How To Avoid Last-Minute CMC Roadblocks To Approval

Post-Pandemic Outsourcing Demand: How Are CDMOs Responding?

Gain Confidence In Clinical Trial Outcomes

Five Best Practices To Ensure Quality Active Pharmaceutical Ingredients

Using The 505(B)(2) Pathway To Streamline Combination Product Approval

Connect With Outsourced Pharma: